Contact Us   |   Print Page   |   Sign In   |   Join
Cutting Edge / Drug Discovery & Development
Share |

Join representatives from Michigan's drug development community for education, networking, and industry analysis at the Cutting Edge Drug Discovery Symposium brought to you by MichBio and the Michigan University Research Corridor

Academic drug discovery has emerged greatly as an adjunct approach to traditional pharmaceutical development in the drive to deliver innovative new medicines. The Cutting Edge / Drug Discovery & Development in Michigan Symposium will showcase drug R&D activities at the state’s research institutions and biotech/pharma companies and discuss their science, capabilities, and enterprises. The program is meant to bring together representatives from academia and the bio-industry, as well as others, to talk about Michigan’s current drug discovery efforts and future capacity for partnerships.  

 

This symposium is presented by MichBio, the biosciences trade association for the state of Michigan, and the University Research Corridor, an academic research cluster leading innovation in Michigan and the Great Lakes region (an alliance of Michigan State University, the University of Michigan, and Wayne State University). The symposium is hosted by the University of Michigan. 

 

The Symposium will feature a poster sessionSubmit your abstract to stephen@michbio.org to be considered.

Be sure to check out the Drug Development Workshop on Monday, November 11th!

 

Featured Speaker

Peter Meinke, Ph.D

Sanders Director, Tri-Institutional Therapeutics Discovery Institute

 

Dr. Peter T. Meinke has extensive experience in all stages of drug discovery from target validation through early clinical development. Programs under Peter’s direct supervision produced one drug (NS5A inhibitor elbasvir for hepatitis C for which he was recognized with the ACS Heroes of Chemistry award in 2017) plus 13 development compounds that advanced into the clinic in seven distinct therapeutic areas. In addition, Peter has significant international experience and, from 2008-2016, focused on working and living overseas (Shanghai, China) to direct and mentor drug discovery research teams globally while managing the attendant business issues. 

 

Peter currently is Sanders Director at the Tri-Institutional Therapeutics Discovery Institute (appointed May 2018) and also is Assistant Professor, Pharmacology, at Weill Cornell Medicine. Following his retirement from Merck Research Laboratories in 2016, Peter held joint appointments at the Tri-Institutional Therapeutics Discovery Institute (VP, Preclinical Development) and at Bridge Medicines (VP, Chemistry), both from Jan-2017 – May-2018. 

 

Peter previously held the title of Executive Director, Discovery Chemistry at Merck. He joined Merck in 1989 following undergraduate (Eckerd College, FL, 1978-1982), doctoral (Syracuse University, NY, G. A. Krafft, 1982-1987) and post-doctoral (Columbia University, NY, W. Clark Still, 1987-1989) education. He is co-author on over 90 publications in peer reviewed journals and co-inventor on more than 35 patents.

 



Be Sure to Visit These Symposium Exhibitors  

     



 

   
     
     
     

 

 

The Cutting Edge Drug Discovery Symposium is Presented by:

 

             


 

 

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal